Improving access to screening and treatment of hepatocellular carcinoma in the United States
- PMID: 38841196
- PMCID: PMC11152816
- DOI: 10.1097/CLD.0000000000000219
Improving access to screening and treatment of hepatocellular carcinoma in the United States
Conflict of interest statement
The authors have no conflicts to report.
Figures
References
-
- Nahon P Najean M Layese R Zarca K Segar LB Cagnot C et al. . ANRS CO12 CirVir; ANRS CO22 Hepather; Scientific Committee–Voting members; CIRRAL groups . Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis. JHEP Rep. 2021;4:100390. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources